MedTrace Logo

Smoking Cessation in Cancer Treatment

NCT03328962 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2019-08-21

No results posted yet for this study

Summary

The intervention to be studied is a smoking cessation program offered to newly diagnosed cancer patients at their first consultation for treatment at an oncological hospital department.

Conditions

  • Smoking Cessation
  • Motivation

Interventions

BEHAVIORAL

Structured smoking cessation counselling based on motivational interviewing (MI) and adapted for the cancer setting eventually combined with provision of smoking cessation medication

structured smoking cessation counselling based on MI and adapted for the cancer setting eventually combined with provision of smoking cessation medication

Sponsors & Collaborators

  • Norwegian Cancer Society

    collaborator OTHER

  • Helse Stavanger HF

    collaborator OTHER_GOV

  • Oslo University Hospital

    collaborator OTHER

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • University Hospital of North Norway

    collaborator OTHER

  • Helse Møre og Romsdal HF

    collaborator OTHER_GOV

  • St. Olavs Hospital

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2020-12-31
Completion
2021-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03328962 on ClinicalTrials.gov